Welcome to the Oncomine Blog
-
Fusion detection in precision oncology, tradeoff decisions and genomic profiling democratization - An Interview with Dr. Eric Vail
Dr. Eric Vail is Director of Molecular Pathology, Cedars-Sinai Medical Center, Los Angeles, Californ... -
Improving Patient Access to Homologous Recombination Deficiency Testing for Precision Oncology
Introduction While next-generation sequencing (NGS) has enabled molecular characterization of tumors... -
Comprehensive Genomic Profiling (CGP): Accelerating Progress in Precision oncology
Comprehensive genomic profiling (CGP) is one of the latest innovations in next-generation sequencing... -
What is Biomarker Testing and Why is it Important in Oncology?
Thermo Fisher Scientific is committed to bringing advanced molecular testing to clinicians and their... -
RET Aberrations and EGFR Exon 20 Insertions Testing in the Complex NSCLC Biomarker Landscape
In his recent OncomineWorld webinar, Dr. Fernando López-Ríos, MD, PhD (Department of Pathology, 12 d... -
The Impact of Rapid Molecular Diagnosis on Precision Medicine in Acute Myeloid Leukemia
Advances in next-generation sequencing have improved our understanding of the complexity and molecul... -
How Diagnostics can Revolutionize Patient Care: Insights from the Precision Medicine Leader Summit
Precision medicine is a holistic approach to healthcare that combines knowledge of an individuals’ g... -
Let’s Do It Ourselves - A global expert consensus is emerging: by retaining oncology biomarker testing in-house, healthcare management and patient care benefit significantly
Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have pro... -
A Comprehensive Answer for Cancer: Is Comprehensive Genomic Profiling Always the Right Approach?
What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of g...